A Phase 3B, Randomized, Double-Blind, Placebo-Controlled, Parallel-Treatment Group, Multicenter Efficacy and Safety Study of Topical Diltiazem Hydrochloride 2% Cream in Subjects With Anal Fissure
Latest Information Update: 21 May 2014
At a glance
- Drugs Diltiazem (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Ventrus Biosciences
- 12 Feb 2014 Primary endpoint 'Significant difference in change in pain intensity during or after defecation been treatment and placebo' has not been met, as reporrted by a Ventrus Biosciences media release.
- 12 Feb 2014 Top-line results reported in a Ventrus Biosciences media release.
- 30 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.